CELLDEX THERAPEUTICS INC
CLDX · NASDAQ
Updated at 2026-10-13 14:31:30
- Today's High
- $29.30
- Today’s Low
- $28.50
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $29.61
- Previous Close
- $29.43
- Volume
- 596.41K
- Market Cap
- $2.31B
- P/E Ratio
- --
- EPS
- $-4.35
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- PERRYVILLE III BUILDING, HAMPTON, NJ, UNITED STATES, 08827
- Country
- US
- Listing Date
- 1986-05-15
- Fiscal Year End
- December
- Shares Outstanding
- 78.49M
- CIK
- 0000744218
- Website
- celldex.com
Celldex Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development of therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. The company is headquartered in Hampton, New Jersey.
Financial Metrics
Revenue
2026-06-30
$22K
2026-03-31
$15K
2025-12-31
$75K
2025-09-30
$0
Operating Expenses
2026-06-30
$80.64M
2026-03-31
$83.59M
2025-12-31
$87.26M
2025-09-30
$10.68M
Net Income
2026-06-30
-$73.5M
2026-03-31
-$78.68M
2025-12-31
-$81.36M
2025-09-30
-$67.04M
Net Profit Margin
2026-06-30
-334.1K%
2026-03-31
-524.56K%
2025-12-31
-108.48K%
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.94
2026-03-31
$-1.18
2025-12-31
$-1.22
2025-09-30
$-1.01
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$72.6M
2026-03-31
-$77.83M
2025-12-31
-$80.54M
2025-09-30
-$66.22M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $22K | $15K | $75K | $0 |
| Operating Expenses | $80.64M | $83.59M | $87.26M | $10.68M |
| Net Income | -$73.5M | -$78.68M | -$81.36M | -$67.04M |
| Net Profit Margin | -334.1K% | -524.56K% | -108.48K% | -- |
| Earnings Per Share | $-0.94 | $-1.18 | $-1.22 | $-1.01 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$72.6M | -$77.83M | -$80.54M | -$66.22M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.